CN106924230A
|
|
Application of the Dithranol in the flaviviridae infections such as anti-zika virus
|
CN106860461A
|
|
Application of the thonzonium bromide in anti-human cytomegalovirus infection
|
CN106749278A
|
|
The preparation and its application of triazole compound
|
CN106883234A
|
|
The preparation and its application of amides compound
|
CN106883235A
|
|
The preparation and application of furodiazole compound
|
CN106399456A
|
|
Purpose of aprotinin and determination method of Zika virus non-structure protease activity
|
CN106434849A
|
|
Activity determination buffer solution and activity determination method of high-throughput Zika virus non-structural protease
|
CN106166153A
|
|
The application in preparation treatment SARS medicine of a kind of asymmetric fragrance disulfide compound containing five-ring heterocycles
|
CN105837487A
|
|
Small-molecule inhibitor against MERS-CoV main protease, and preparation method and application thereof
|
CN106905532A
|
|
The polymer micelle of side chain with PAMAM and preparation method thereof
|
CN105412151A
|
|
Inhibitor aiming at coronavirus main protease, and application of Zn<2+>
|
CN106588764A
|
|
Hepatitis C virus inhibitors
|
CN106565529A
|
|
3-(2-((3-formamyl-4-hydroxyl)benzyloxy)-5-(substituted benzoyl)phenylpropionic acid derivative and preparation method and application thereof
|
CN106551402A
|
|
Super prebioticses and preparation method thereof
|
CN106474299A
|
|
A kind of Chinese medicine composition and its preparation method and application
|
CN106279143A
|
|
Thiazole heterocycle compounds and its preparation method and application
|
CN106188006A
|
|
Containing 1,2,3 triazole heterocycle compounds and its preparation method and application
|
CN106188028A
|
|
Containing oxadiazoles heterocycle compound and its preparation method and application
|
CN106187995A
|
|
Amide bond heterocycle compound and its preparation method and application
|
CN106188005A
|
|
Containing triazole heterocycle compound and its preparation method and application
|